|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Silverback Therapeutics (NASDAQ: SBTX) through any online brokerage.
There are no as such competitors for Silverback Therapeutics.
The latest price target for Silverback Therapeutics (NASDAQ: SBTX) was reported by SVB Leerink on 2021-04-06. The analyst firm set a price target for 49.00 expecting SBTX to rise to within 12 months (a possible 74.01% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Silverback Therapeutics (NASDAQ: SBTX) is $28.16 last updated Fri May 07 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Silverback Therapeutics.
There is no upcoming split for Silverback Therapeutics.